![1]()
Opinion
Masks, fear, and loss of connection in the era of COVID-19
May 14, 2020
The deep feeling of connection with patients feels like “fraying threads moving further apart,” because of the havoc created by the coronavirus.
![1]()
Opinion
The third surge: Are we prepared for the non-COVID crisis?
May 13, 2020
Health systems should be prepared for a “third surge” of patients coming in with chronic medical conditions.
![1]()
News
States vary in vulnerability to COVID-19 impact
May 12, 2020
Medical support is needed, but “many people are harmed by the economic effects of the pandemic.”
![1]()
News
European COVID-19 insights: Try helmet CPAP
April 23, 2020
An older, relatively inexpensive form of noninvasive ventilation appears to prevent self-induced lung injury.
![1]()
News
Researchers investigate impact of smoking on COVID-19 risk
April 20, 2020
Early reports from China showed a case fatality rate of 4.7% for men, compared with 2.8% for women.
![1]()
News
Readmission for COPD exacerbation upped in-hospital mortality risk
October 25, 2019
NEW ORLEANS – Reduction of readmission rates has potential to improve health and economic outcomes, according to researchers.
![1]()
News
Opioids, benzodiazepines carry greater risk of COPD-related hospitalization
October 25, 2019
The risk of hospitalization because of respiratory events for patients with COPD was especially high when opioid and benzodiazepine medications were combined.
![1]()
News
Influenza vaccination modestly reduces risk of hospitalizations in patients with COPD
October 9, 2019
Older patients with COPD need more effective influenza vaccines and other preventive strategies.
![1]()
News
Patients with COPD at heightened risk for community-acquired pneumonia requiring hospitalization
July 11, 2019
COPD patients were about 18 times more likely to develop community-acquired pneumonia requiring hospitalization.
News
C-reactive protein testing reduced antibiotic prescribing in patients with COPD exacerbation
July 10, 2019
Fewer prescriptions, less reported antibiotic use, with no evidence of harm or reduced quality of life, according to PACE trial investigators.
